tirzepatide covered by blue cross blue shield Weight Loss Injections & Clinics Near You IBX members face GLP-1 drug

Researchers continue studying Retatrutide in relation to incretin signaling and multi-pathway metabolic research

University of Oklahoma researcher Elizabeth Wellberg, Ph.D., is the senior author of a review article in The Journal of Clinical Investigation that gathers current research evidence about the effects of GLP-1 drugs, like Ozempic and Zepbound, on cancer risk.

We benchmarked the GLP-1RA age-counteracting effects against those of mTOR inhibition, a well-estab...

Hard-shell body with secure single latch closure

These medications, known as GLP-1 receptor agonists , are reshaping the approach to managing weight, blood sugar control, and even chroni

Weight loss Journeys often bring incredible transformations, but they can also come with unexpected side effects, like hair loss/shedding